Skip to main content
Premium Trial:

Request an Annual Quote

Dirk Ehlers, Ulrich Kintzel, Matthias Guth

Protagen announced new members to its supervisory board. Dirk Ehlers, CEO of Trumpf Medical, was elected to Protagen's board, while Ulrich Kintzel, senior investment manager of NRW.Bank, and Matthias Guth of MIG have joined the board succeeding colleagues from their respective firms. 

Elhers has held executive positions at Eppendorf, Roche Diagnostics, Evotec, Fresenius Kabi, and Olympus Diagnostics. Kintzel succeeds Aristotelis Nastos as the board representative from NRW.Bank. Guth follows Michael Motschmann as the board representative from MIG.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.